188 related articles for article (PubMed ID: 31083670)
1. Knockdown of PTOV1 and PIN1 exhibit common phenotypic anti-cancer effects in MDA-MB-231 cells.
Karna SKL; Ahmad F; Lone BA; Pokharel YR
PLoS One; 2019; 14(5):e0211658. PubMed ID: 31083670
[TBL] [Abstract][Full Text] [Related]
2. SUPT5H Post-Transcriptional Silencing Modulates PIN1 Expression, Inhibits Tumorigenicity, and Induces Apoptosis of Human Breast Cancer Cells.
Lone BA; Ahmad F; Karna SKL; Pokharel YR
Cell Physiol Biochem; 2020 Sep; 54(5):928-946. PubMed ID: 32961044
[TBL] [Abstract][Full Text] [Related]
3. Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.
Kim JH; Jung JH; Kim SH; Jeong SJ
Phytother Res; 2014 Feb; 28(2):238-44. PubMed ID: 23580332
[TBL] [Abstract][Full Text] [Related]
4. Pin1 modulates chemo-resistance by up-regulating FoxM1 and the involvements of Wnt/β-catenin signaling pathway in cervical cancer.
Wang T; Liu Z; Shi F; Wang J
Mol Cell Biochem; 2016 Feb; 413(1-2):179-87. PubMed ID: 26820938
[TBL] [Abstract][Full Text] [Related]
5. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of the prolyl isomerase Pin1 inhibits Hep-2 cell growth, migration, and invasion by targeting the β-catenin signaling pathway.
Fan G; Wang L; Xu J; Jiang P; Wang W; Huang Y; Lv M; Liu S
Biochem Cell Biol; 2018 Dec; 96(6):734-741. PubMed ID: 29768138
[TBL] [Abstract][Full Text] [Related]
7. Pin1 promotes prostate cancer cell proliferation and migration through activation of Wnt/β-catenin signaling.
Zhu Z; Zhang H; Lang F; Liu G; Gao D; Li B; Liu Y
Clin Transl Oncol; 2016 Aug; 18(8):792-7. PubMed ID: 26497355
[TBL] [Abstract][Full Text] [Related]
8. H-Ras induces Nrf2-Pin1 interaction: Implications for breast cancer progression.
Saeidi S; Kim SJ; Han HJ; Kim SH; Zheng J; Lee HB; Han W; Noh DY; Na HK; Surh YJ
Toxicol Appl Pharmacol; 2020 Sep; 402():115121. PubMed ID: 32621833
[TBL] [Abstract][Full Text] [Related]
9. Depleting PTOV1 sensitizes non-small cell lung cancer cells to chemotherapy through attenuating cancer stem cell traits.
Wu Z; Liu Z; Jiang X; Mi Z; Meng M; Wang H; Zhao J; Zheng B; Yuan Z
J Exp Clin Cancer Res; 2019 Aug; 38(1):341. PubMed ID: 31387622
[TBL] [Abstract][Full Text] [Related]
10. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
11. Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways.
Zhang Z; Yu W; Zheng M; Liao X; Wang J; Yang D; Lu W; Wang L; Zhang S; Liu H; Zhou XZ; Lu KP
Mol Carcinog; 2019 Aug; 58(8):1450-1464. PubMed ID: 31026381
[TBL] [Abstract][Full Text] [Related]
12. Impact of PIN1 Inhibition on Tumor Progression and Chemotherapy Sensitivity in Colorectal Cancer.
Gholamzadeh Khoei S; Saidijam M; Amini R; Jalali A; Najafi R
J Gastrointest Cancer; 2022 Jun; 53(2):299-310. PubMed ID: 33580870
[TBL] [Abstract][Full Text] [Related]
13. G Protein-coupled Receptor Kinase 2 (GRK2) Promotes Breast Tumorigenesis Through a HDAC6-Pin1 Axis.
Nogués L; Reglero C; Rivas V; Salcedo A; Lafarga V; Neves M; Ramos P; Mendiola M; Berjón A; Stamatakis K; Zhou XZ; Lu KP; Hardisson D; Mayor F; Penela P
EBioMedicine; 2016 Nov; 13():132-145. PubMed ID: 27720394
[TBL] [Abstract][Full Text] [Related]
14. Peptidyl-prolyl cis/trans-isomerase A1 (Pin1) is a target for modification by lipid electrophiles.
Aluise CD; Rose K; Boiani M; Reyzer ML; Manna JD; Tallman K; Porter NA; Marnett LJ
Chem Res Toxicol; 2013 Feb; 26(2):270-9. PubMed ID: 23231502
[TBL] [Abstract][Full Text] [Related]
15. PIN1 Inhibition Sensitizes Chemotherapy in Gastric Cancer Cells by Targeting Stem Cell-like Traits and Multiple Biomarkers.
Zhang ZZ; Yu WX; Zheng M; Liao XH; Wang JC; Yang DY; Lu WX; Wang L; Zhang S; Liu HK; Zhou XZ; Lu KP
Mol Cancer Ther; 2020 Mar; 19(3):906-919. PubMed ID: 31879364
[TBL] [Abstract][Full Text] [Related]
16. Celastrol strongly inhibits proliferation, migration and cancer stem cell properties through suppression of Pin1 in ovarian cancer cells.
Li X; Wang H; Ding J; Nie S; Wang L; Zhang L; Ren S
Eur J Pharmacol; 2019 Jan; 842():146-156. PubMed ID: 30389635
[TBL] [Abstract][Full Text] [Related]
17. Peptidyl-prolyl cis/trans isomerase Pin1 regulates withaferin A-mediated cell cycle arrest in human breast cancer cells.
Samanta SK; Lee J; Hahm ER; Singh SV
Mol Carcinog; 2018 Jul; 57(7):936-946. PubMed ID: 29603395
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of SF3B1 inhibits cell proliferation, invasion and migration triggering apoptosis in breast cancer via aberrant splicing.
Zhang L; Zhang X; Zhang H; Liu F; Bi Y; Zhang Y; Cheng C; Liu J
Breast Cancer; 2020 May; 27(3):464-476. PubMed ID: 31919642
[TBL] [Abstract][Full Text] [Related]
19. PIN1 in hepatocellular carcinoma is associated with TP53 gene status.
Bae JS; Noh SJ; Kim KM; Jang KY; Park HS; Chung MJ; Park BH; Moon WS
Oncol Rep; 2016 Oct; 36(4):2405-11. PubMed ID: 27499097
[TBL] [Abstract][Full Text] [Related]
20. Pin1 expression contributes to lung cancer: Prognosis and carcinogenesis.
Tan X; Zhou F; Wan J; Hang J; Chen Z; Li B; Zhang C; Shao K; Jiang P; Shi S; Feng X; Lv N; Wang Z; Ling Y; Zhao X; Ding D; Sun J; Xiong M; He J
Cancer Biol Ther; 2010 Jan; 9(2):111-9. PubMed ID: 20009523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
